Overview
Zollinger–Ellison syndrome (ZES) is a rare neuroendocrine disorder in which one or more tumors—called gastrinomas—form in the pancreas, duodenum, or rarely the stomach. These tumors secrete excessive amounts of the hormone gastrin, causing the stomach to produce far more acid than normal. The resulting hyperacidity leads to multiple, often refractory peptic ulcers, diarrhea, and malabsorption.
Although ZES accounts for only ~0.1% of all peptic ulcer disease, it is clinically important because the ulcers tend to be large, multiple, and located distal to the duodenum, and they frequently recur despite standard ulcer therapy.
Who it affects: The condition can appear at any age but most commonly presents in the 4th–5th decade of life. Both sexes are affected equally. About 25–30% of patients have an inherited form called multiple endocrine neoplasia type 1 (MEN‑1), which runs in families.
Prevalence: Estimated incidence is 0.5–2 cases per million people per year in the United States, with a prevalence of roughly 1–3 cases per 100,000 people.[1]
Symptoms
Symptoms stem from acid hypersecretion, tumor mass effect, and, in MEN‑1, involvement of other endocrine organs. Not all patients have every symptom.
Gastro‑intestinal symptoms
- Recurrent abdominal pain – typically epigastric, worse after meals.
- Peptic ulcers – may be multiple, >2 cm, located in the duodenum, jejunum, or even colon.
- Diarrhea – watery, sometimes greasy, caused by acid inactivating pancreatic enzymes.
- Nausea & vomiting – especially when ulcers bleed or perforate.
- Weight loss – due to malabsorption and chronic diarrhea.
Systemic & endocrine symptoms (especially in MEN‑1)
- Hyperparathyroidism – kidney stones, bone pain.
- Pituitary adenomas – headaches, visual changes, hormonal imbalances.
- Fatigue & weakness – secondary to electrolyte loss (e.g., hypokalemia).
Red‑flag symptoms that suggest a complication
- Vomiting of blood (hematemesis) or black, tarry stools (melena).
- Sudden, severe abdominal pain indicating perforation.
- Persistent vomiting that prevents oral intake.
Causes and Risk Factors
Zollinger–Ellison syndrome is fundamentally a gastrin‑producing neuroendocrine tumor. The cause can be divided into sporadic and hereditary forms.
1. Sporadic gastrinomas
- Arise de novo in pancreatic islet cells or duodenal Brunner’s glands.
- Exact molecular triggers are unclear, but somatic mutations in the MEN1 gene, CDKN1B, and VHL have been documented.[2]
2. Familial (MEN‑1 associated) ZES
- Autosomal‑dominant inheritance of a germ‑line mutation in the MEN1 tumor suppressor gene.
- Up to 30% of ZES patients have MEN‑1, and those patients often develop multiple gastrinomas rather than a single tumor.
Risk Factors
- Family history of MEN‑1 or ZES.
- Age – although anyone can be affected, most diagnoses occur after age 30.
- Genetic mutations in MEN1, CDKN1B, or other neuroendocrine tumor‑related genes.
- There are no lifestyle risk factors (e.g., smoking, alcohol) that directly cause ZES, but they can worsen ulcer disease.
Diagnosis
Because the clinical picture can mimic ordinary peptic ulcer disease, a systematic approach is essential.
1. Biochemical testing
- Fasting serum gastrin level – a level > 1,000 pg/mL (10‑fold above normal) in the presence of stomach acidity is highly suggestive.[3]
- Secretin stimulation test – paradoxical rise in gastrin after IV secretin confirms gastrinoma when basal gastrin is equivocal.
- Gastric pH measurement – pH <2 confirms hyperacidity.
2. Imaging studies
- Endoscopic ultrasound (EUS) – high sensitivity for small (<1 cm) pancreatic/duodenal lesions.
- Multiphasic contrast CT or MRI – evaluates tumor size, location, and liver metastases.
- Somatostatin receptor scintigraphy (Octreoscan) or ^68Ga‑DOTATATE PET/CT – detects both primary tumors and metastases because most gastrinomas express somatostatin receptors.
3. Endoscopic assessment
- Upper endoscopy (EGD) to visualize ulcers, obtain biopsies (to exclude H. pylori or malignancy), and sometimes locate small duodenal gastrinomas.
4. Genetic testing
- Indicated when MEN‑1 is suspected (family history, concurrent endocrine tumors). Testing for MEN1 mutations guides surveillance for other organ involvement.
Treatment Options
Therapy aims to control acid hypersecretion, eradicate or control tumor growth, and address complications.
1. Acid‑suppression therapy (cornerstone)
- High‑dose proton pump inhibitors (PPIs) – e.g., omeprazole 40–80 mg daily or equivalent. PPIs normalize gastric pH in > 95% of patients and heal ulcers.[4]
- H2‑receptor antagonists (ranitidine, famotidine) are less effective but may be used adjunctively.
2. Surgical management
- Curative resection – indicated when a single, localized gastrinoma is identified without metastasis. Options: pancreaticoduodenectomy, enucleation, or duodenal wedge resection.
- Debulking surgery – for patients with liver metastases; reduces tumor burden and gastrin output.
- In MEN‑1 patients, surgery is controversial because tumors are often multifocal; medical control is preferred unless severe disease.
3. Medical therapy for tumor control
- Somatostatin analogues (octreotide, lanreotide) – inhibit gastrin release and may shrink tumors, especially in metastatic disease.
- Targeted therapy – everolimus (mTOR inhibitor) and sunitinib (tyrosine‑kinase inhibitor) are approved for advanced pancreatic neuroendocrine tumors and can be considered.
- Chemotherapy – reserved for high‑grade, rapidly progressive disease; regimens include streptozocin‑based combos.
4. Management of complications
- Endoscopic hemostasis for bleeding ulcers.
- IV proton pump inhibitor infusion in acute perforation.
- Electrolyte repletion (potassium, magnesium) for chronic diarrhea.
- Vitamin B12 and iron supplementation when malabsorption is present.
5. Lifestyle & supportive measures
- Small, frequent meals; avoid foods that trigger acid (citrus, coffee, spicy foods).
- Smoking cessation and limiting alcohol, both of which increase ulcer risk.
- Vaccination against Helicobacter pylori (test and treat if positive) to reduce additional ulcer burden.
Living with Zollinger–Ellison syndrome (gastric ulcer disease)
Although ZES is a chronic condition, most patients lead active lives with proper management.
- Medication adherence – take PPIs exactly as prescribed; missing doses can precipitate ulcer recurrence.
- Regular follow‑up – serum gastrin and imaging every 6–12 months to monitor tumor status.
- Nutrition – high‑protein, low‑fat diet improves nutrient absorption; consider a dietitian’s guidance for malabsorption.
- Hydration – replace fluids lost through diarrhea; oral rehydration solutions are useful.
- Monitor for MEN‑1 manifestations – annual calcium, parathyroid hormone, and pituitary hormone testing if genetically predisposed.
- Psychosocial support – chronic illness can cause anxiety; counseling or support groups (e.g., NET Patient Foundation) are beneficial.
Prevention
Because ZES is primarily driven by tumor genetics, primary prevention is limited. However, secondary preventive steps can reduce ulcer complications:
- Screen for and eradicate H. pylori infection, which can worsen acid‑related injury.
- Avoid chronic NSAID or aspirin use unless medically necessary; use gastro‑protective agents if needed.
- Maintain a healthy weight and avoid smoking, which aggravate gastric mucosal injury.
- For individuals with a known MEN‑1 mutation, engage in a structured surveillance program (annual labs & imaging) to detect gastrinomas early.
Complications
If left untreated or inadequately controlled, ZES may lead to serious health problems:
- Refractory or perforated peptic ulcers – risk of peritonitis and sepsis.
- Upper gastrointestinal bleeding – can be life‑threatening.
- Malabsorption and nutritional deficiencies – especially fat‑soluble vitamins (A, D, E, K) and vitamin B12.
- Gastric outlet obstruction – from ulcer scarring.
- Metastatic disease – liver is the most common site; spread can cause liver dysfunction and hormonal sequelae.
- Carcinoid syndrome – rare, but possible with extensive neuroendocrine tumor burden.
When to Seek Emergency Care
- Sudden, severe abdominal pain that does not improve with usual medication.
- Vomiting blood (bright red) or material that looks like coffee grounds.
- Black, tarry stools (melena) indicating upper GI bleeding.
- Signs of a perforated ulcer: sudden sharp pain, fever, abdominal rigidity, or swelling.
- Profound weakness, dizziness, or fainting—possible severe blood loss or electrolyte imbalance.
Sources:
```